A molecule in cells that shuts down the expression of genes might be a promising target for new drugs designed to treat glioblastoma, the most frequent and lethal form of brain cancer. The findings suggest that the protein PRMT5 is a possible prognostic factor and therapeutic target for glioblastoma, and they provide a rationale for developing agents that target PRMT5 in this deadly disease.
Fuente : http://www.eurekalert.org/pub_releases/2014-02/osu...
Fuente : http://www.eurekalert.org/pub_releases/2014-02/osu...